{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:57:10Z","timestamp":1779364630249,"version":"3.53.0"},"reference-count":67,"publisher":"Aging and Disease","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2021]]},"DOI":"10.14336\/ad.2021.0404","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T17:42:57Z","timestamp":1633023777000},"page":"1753","source":"Crossref","is-referenced-by-count":38,"title":["Targeting Mitochondrial Network Disorganization is Protective in <i>C. elegans<\/i> Models of Huntington\u2019s Disease"],"prefix":"10.14336","volume":"12","author":[{"given":"Emily","family":"Machiela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige D","family":"Rudich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Traa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Anglas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja K","family":"Soo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M","family":"Senchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M","family":"Van Raamsdonk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2021.0404-1","doi-asserted-by":"crossref","unstructured":"Slow EJ, Van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, et al. (2003). Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet, 12:1555-1567.","DOI":"10.1093\/hmg\/ddg169"},{"key":"key-10.14336\/AD.2021.0404-2","doi-asserted-by":"crossref","unstructured":"Van Raamsdonk JM, Pearson J, Rogers DA, Bissada N, Vogl AW, Hayden MR, et al. (2005). Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease. Hum Mol Genet, 14:1379-1392.","DOI":"10.1093\/hmg\/ddi147"},{"key":"key-10.14336\/AD.2021.0404-3","doi-asserted-by":"crossref","unstructured":"Ross CA, Tabrizi SJ (2011). Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol, 10:83-98.","DOI":"10.1016\/S1474-4422(10)70245-3"},{"key":"key-10.14336\/AD.2021.0404-4","doi-asserted-by":"crossref","unstructured":"Lee JM, Galkina EI, Levantovsky RM, Fossale E, Anne Anderson M, Gillis T, et al. (2013). Dominant effects of the Huntington\u2019s disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy. Hum Mol Genet, 22:3227-3238.","DOI":"10.1093\/hmg\/ddt176"},{"key":"key-10.14336\/AD.2021.0404-5","unstructured":"Lee JM, Ramos EM, Lee JH, Gillis T, Mysore JS, Hayden MR, et al. (2012). CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology, 78:690-695."},{"key":"key-10.14336\/AD.2021.0404-6","doi-asserted-by":"crossref","unstructured":"Costa V, Scorrano L (2012). Shaping the role of mitochondria in the pathogenesis of Huntington\u2019s disease. EMBO J, 31:1853-1864.","DOI":"10.1038\/emboj.2012.65"},{"key":"key-10.14336\/AD.2021.0404-7","doi-asserted-by":"crossref","unstructured":"Oliveira JM (2010). Nature and cause of mitochondrial dysfunction in Huntington\u2019s disease: focusing on huntingtin and the striatum. J Neurochem, 114:1-12.","DOI":"10.1111\/j.1471-4159.2010.06741.x"},{"key":"key-10.14336\/AD.2021.0404-8","doi-asserted-by":"crossref","unstructured":"Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, et al. (1997). Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia. Ann Neurol, 41:646-653.","DOI":"10.1002\/ana.410410514"},{"key":"key-10.14336\/AD.2021.0404-9","doi-asserted-by":"crossref","unstructured":"Jenkins BG, Koroshetz WJ, Beal MF, Rosen BR (1993). Evidence for impairment of energy metabolism in vivo in Huntington\u2019s disease using localized 1H NMR spectroscopy. Neurology, 43:2689-2695.","DOI":"10.1212\/WNL.43.12.2689"},{"key":"key-10.14336\/AD.2021.0404-10","doi-asserted-by":"crossref","unstructured":"Seong IS, Ivanova E, Lee JM, Choo YS, Fossale E, Anderson M, et al. (2005). HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum Mol Genet, 14:2871-2880.","DOI":"10.1093\/hmg\/ddi319"},{"key":"key-10.14336\/AD.2021.0404-11","doi-asserted-by":"crossref","unstructured":"Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, et al. (2002). Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci, 5:731-736.","DOI":"10.1038\/nn884"},{"key":"key-10.14336\/AD.2021.0404-12","doi-asserted-by":"crossref","unstructured":"Trushina E, Dyer RB, Badger JD, 2nd, Ure D, Eide L, Tran DD, et al. (2004). Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol, 24:8195-8209.","DOI":"10.1128\/MCB.24.18.8195-8209.2004"},{"key":"key-10.14336\/AD.2021.0404-13","doi-asserted-by":"crossref","unstructured":"Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, et al. (1993). Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci, 13:4181-4192.","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993"},{"key":"key-10.14336\/AD.2021.0404-14","doi-asserted-by":"crossref","unstructured":"Borlongan CV, Koutouzis TK, Sanberg PR (1997). 3-Nitropropionic acid animal model and Huntington\u2019s disease. Neurosci Biobehav Rev, 21:289-293.","DOI":"10.1016\/S0149-7634(96)00027-9"},{"key":"key-10.14336\/AD.2021.0404-15","unstructured":"Genetic Modifiers of Huntington\u2019s Disease C (2015). Identification of Genetic Factors that Modify Clinical Onset of Huntington\u2019s Disease. Cell, 162:516-526."},{"key":"key-10.14336\/AD.2021.0404-16","doi-asserted-by":"crossref","unstructured":"Wang H, Lim PJ, Karbowski M, Monteiro MJ (2009). Effects of overexpression of huntingtin proteins on mitochondrial integrity. Hum Mol Genet, 18:737-752.","DOI":"10.1093\/hmg\/ddn404"},{"key":"key-10.14336\/AD.2021.0404-17","doi-asserted-by":"crossref","unstructured":"Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y, et al. (2011). Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med, 17:377-382.","DOI":"10.1038\/nm.2313"},{"key":"key-10.14336\/AD.2021.0404-18","doi-asserted-by":"crossref","unstructured":"Haun F, Nakamura T, Shiu AD, Cho DH, Tsunemi T, Holland EA, et al. (2013). S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington\u2019s disease. Antioxid Redox Signal, 19:1173-1184.","DOI":"10.1089\/ars.2012.4928"},{"key":"key-10.14336\/AD.2021.0404-19","doi-asserted-by":"crossref","unstructured":"Guo X, Disatnik MH, Monbureau M, Shamloo M, Mochly-Rosen D, Qi X (2013). Inhibition of mitochondrial fragmentation diminishes Huntington\u2019s disease-associated neurodegeneration. J Clin Invest, 123:5371-5388.","DOI":"10.1172\/JCI70911"},{"key":"key-10.14336\/AD.2021.0404-20","doi-asserted-by":"crossref","unstructured":"Jin YN, Yu YV, Gundemir S, Jo C, Cui M, Tieu K, et al. (2013). Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin. PLoS One, 8:e57932.","DOI":"10.1371\/journal.pone.0057932"},{"key":"key-10.14336\/AD.2021.0404-21","doi-asserted-by":"crossref","unstructured":"Joshi AU, Ebert AE, Haileselassie B, Mochly-Rosen D (2019). Drp1\/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington\u2019s disease. J Mol Cell Cardiol, 127:125-133.","DOI":"10.1016\/j.yjmcc.2018.12.004"},{"key":"key-10.14336\/AD.2021.0404-22","doi-asserted-by":"crossref","unstructured":"Liot G, Bossy B, Lubitz S, Kushnareva Y, Sejbuk N, Bossy-Wetzel E (2009). Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ, 16:899-909.","DOI":"10.1038\/cdd.2009.22"},{"key":"key-10.14336\/AD.2021.0404-23","doi-asserted-by":"crossref","unstructured":"Costa V, Giacomello M, Hudec R, Lopreiato R, Ermak G, Lim D, et al. (2010). Mitochondrial fission and cristae disruption increase the response of cell models of Huntington\u2019s disease to apoptotic stimuli. EMBO Mol Med, 2:490-503.","DOI":"10.1002\/emmm.201000102"},{"key":"key-10.14336\/AD.2021.0404-24","doi-asserted-by":"crossref","unstructured":"Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, et al. (2010). Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease. Hum Mol Genet, 19:3919-3935.","DOI":"10.1093\/hmg\/ddq306"},{"key":"key-10.14336\/AD.2021.0404-25","doi-asserted-by":"crossref","unstructured":"Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA, et al. (2011). Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage. Hum Mol Genet, 20:1438-1455.","DOI":"10.1093\/hmg\/ddr024"},{"key":"key-10.14336\/AD.2021.0404-26","doi-asserted-by":"crossref","unstructured":"Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, et al. (2012). Mutant huntingtin\u2019s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington\u2019s disease. Hum Mol Genet, 21:406-420.","DOI":"10.1093\/hmg\/ddr475"},{"key":"key-10.14336\/AD.2021.0404-27","doi-asserted-by":"crossref","unstructured":"Ciarlo L, Manganelli V, Matarrese P, Garofalo T, Tinari A, Gambardella L, et al. (2012). Raft-like microdomains play a key role in mitochondrial impairment in lymphoid cells from patients with Huntington\u2019s disease. J Lipid Res, 53:2057-2068.","DOI":"10.1194\/jlr.M026062"},{"key":"key-10.14336\/AD.2021.0404-28","doi-asserted-by":"crossref","unstructured":"Cooper JF, Machiela E, Dues DJ, Spielbauer KK, Senchuk MM, Van Raamsdonk JM (2017). Activation of the mitochondrial unfolded protein response promotes longevity and dopamine neuron survival in Parkinson\u2019s disease models. Sci Rep, 7:16441.","DOI":"10.1038\/s41598-017-16637-2"},{"key":"key-10.14336\/AD.2021.0404-29","doi-asserted-by":"crossref","unstructured":"Wu Z, Senchuk MM, Dues DJ, Johnson BK, Cooper JF, Lew L, et al. (2018). Mitochondrial unfolded protein response transcription factor ATFS-1 promotes longevity in a long-lived mitochondrial mutant through activation of stress response pathways. BMC Biol, 16:147.","DOI":"10.1186\/s12915-018-0615-3"},{"key":"key-10.14336\/AD.2021.0404-30","doi-asserted-by":"crossref","unstructured":"Cooper JF, Dues DJ, Spielbauer KK, Machiela E, Senchuk MM, Van Raamsdonk JM (2015). Delaying aging is neuroprotective in Parkinson\u2019s disease: a genetic analysis in C. elegans models. NPJ Parkinsons Dis, 1:15022.","DOI":"10.1038\/npjparkd.2015.22"},{"key":"key-10.14336\/AD.2021.0404-31","doi-asserted-by":"crossref","unstructured":"Van Raamsdonk JM, Hekimi S (2011). FUdR causes a twofold increase in the lifespan of the mitochondrial mutant gas-1. Mech Ageing Dev, 132:519-521.","DOI":"10.1016\/j.mad.2011.08.006"},{"key":"key-10.14336\/AD.2021.0404-32","doi-asserted-by":"crossref","unstructured":"Schaar CE, Dues DJ, Spielbauer KK, Machiela E, Cooper JF, Senchuk M, et al. (2015). Mitochondrial and cytoplasmic ROS have opposing effects on lifespan. PLoS Genet, 11:e1004972.","DOI":"10.1371\/journal.pgen.1004972"},{"key":"key-10.14336\/AD.2021.0404-33","doi-asserted-by":"crossref","unstructured":"Machiela E, Dues DJ, Senchuk MM, Van Raamsdonk JM (2016). Oxidative stress is increased in C. elegans models of Huntington\u2019s disease but does not contribute to polyglutamine toxicity phenotypes. Neurobiol Dis, 96:1-11.","DOI":"10.1016\/j.nbd.2016.08.008"},{"key":"key-10.14336\/AD.2021.0404-34","doi-asserted-by":"crossref","unstructured":"Senchuk MM, Dues DJ, Schaar CE, Johnson BK, Madaj ZB, Bowman MJ, et al. (2018). Activation of DAF-16\/FOXO by reactive oxygen species contributes to longevity in long-lived mitochondrial mutants in Caenorhabditis elegans. PLoS Genet, 14:e1007268.","DOI":"10.1371\/journal.pgen.1007268"},{"key":"key-10.14336\/AD.2021.0404-35","doi-asserted-by":"crossref","unstructured":"Rooney JP, Ryde IT, Sanders LH, Howlett EH, Colton MD, Germ KE, et al. (2015). PCR based determination of mitochondrial DNA copy number in multiple species. Methods in molecular biology (Clifton, N.J.), 1241:23-38.","DOI":"10.1007\/978-1-4939-1875-1_3"},{"key":"key-10.14336\/AD.2021.0404-36","doi-asserted-by":"crossref","unstructured":"Bratic I, Hench J, Henriksson J, Antebi A, B\u00fcrglin TR, Trifunovic A (2009). Mitochondrial DNA level, but not active replicase, is essential for Caenorhabditis elegans development. Nucleic acids research, 37:1817-1828.","DOI":"10.1093\/nar\/gkp018"},{"key":"key-10.14336\/AD.2021.0404-37","doi-asserted-by":"crossref","unstructured":"Wang H, Lim PJ, Yin C, Rieckher M, Vogel BE, Monteiro MJ (2006). Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington\u2019s disease by ubiquilin. Hum Mol Genet, 15:1025-1041.","DOI":"10.1093\/hmg\/ddl017"},{"key":"key-10.14336\/AD.2021.0404-38","doi-asserted-by":"crossref","unstructured":"Machiela E, Liontis T, Dues DJ, Rudich PD, Traa A, Wyman L, et al. (2020). Disruption of mitochondrial dynamics increases stress resistance through activation of multiple stress response pathways. FASEB J, 34:8475-8492.","DOI":"10.1096\/fj.201903235R"},{"key":"key-10.14336\/AD.2021.0404-39","doi-asserted-by":"crossref","unstructured":"Weir HJ, Yao P, Huynh FK, Escoubas CC, Goncalves RL, Burkewitz K, et al. (2017). Dietary Restriction and AMPK Increase Lifespan via Mitochondrial Network and Peroxisome Remodeling. Cell Metab.","DOI":"10.1016\/j.cmet.2017.09.024"},{"key":"key-10.14336\/AD.2021.0404-40","doi-asserted-by":"crossref","unstructured":"Liu YJ, McIntyre RL, Janssens GE, Williams EG, Lan J, van Weeghel M, et al. (2020). Mitochondrial translation and dynamics synergistically extend lifespan in C. elegans through HLH-30. J Cell Biol, 219.","DOI":"10.1083\/jcb.201907067"},{"key":"key-10.14336\/AD.2021.0404-41","doi-asserted-by":"crossref","unstructured":"Morley JF, Brignull HR, Weyers JJ, Morimoto RI (2002). The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A, 99:10417-10422.","DOI":"10.1073\/pnas.152161099"},{"key":"key-10.14336\/AD.2021.0404-42","doi-asserted-by":"crossref","unstructured":"Breckenridge DG, Kang BH, Kokel D, Mitani S, Staehelin LA, Xue D (2008). Caenorhabditis elegans drp-1 and fis-2 regulate distinct cell-death execution pathways downstream of ced-3 and independent of ced-9. Mol Cell, 31:586-597.","DOI":"10.1016\/j.molcel.2008.07.015"},{"key":"key-10.14336\/AD.2021.0404-43","doi-asserted-by":"crossref","unstructured":"Labrousse AM, Zappaterra MD, Rube DA, van der Bliek AM (1999). C. elegans dynamin-related protein DRP-1 controls severing of the mitochondrial outer membrane. Mol Cell, 4:815-826.","DOI":"10.1016\/S1097-2765(00)80391-3"},{"key":"key-10.14336\/AD.2021.0404-44","doi-asserted-by":"crossref","unstructured":"Weir HJ, Yao P, Huynh FK, Escoubas CC, Goncalves RL, Burkewitz K, et al. (2017). Dietary Restriction and AMPK Increase Lifespan via Mitochondrial Network and Peroxisome Remodeling. Cell Metab, 26:884-896 e885.","DOI":"10.1016\/j.cmet.2017.09.024"},{"key":"key-10.14336\/AD.2021.0404-45","doi-asserted-by":"crossref","unstructured":"Lan J, Rollins JA, Zang X, Wu D, Zou L, Wang Z, et al. (2019). Translational Regulation of Non-autonomous Mitochondrial Stress Response Promotes Longevity. Cell Rep, 28:1050-1062 e1056.","DOI":"10.1016\/j.celrep.2019.06.078"},{"key":"key-10.14336\/AD.2021.0404-46","doi-asserted-by":"crossref","unstructured":"Byrne JJ, Soh MS, Chandhok G, Vijayaraghavan T, Teoh JS, Crawford S, et al. (2019). Disruption of mitochondrial dynamics affects behaviour and lifespan in Caenorhabditis elegans. Cell Mol Life Sci, 76:1967-1985.","DOI":"10.1007\/s00018-019-03024-5"},{"key":"key-10.14336\/AD.2021.0404-47","doi-asserted-by":"crossref","unstructured":"Waterham HR, Koster J, van Roermund CW, Mooyer PA, Wanders RJ, Leonard JV (2007). A lethal defect of mitochondrial and peroxisomal fission. N Engl J Med, 356:1736-1741.","DOI":"10.1056\/NEJMoa064436"},{"key":"key-10.14336\/AD.2021.0404-48","doi-asserted-by":"crossref","unstructured":"Ichishita R, Tanaka K, Sugiura Y, Sayano T, Mihara K, Oka T (2008). An RNAi screen for mitochondrial proteins required to maintain the morphology of the organelle in Caenorhabditis elegans. J Biochem, 143:449-454.","DOI":"10.1093\/jb\/mvm245"},{"key":"key-10.14336\/AD.2021.0404-49","doi-asserted-by":"crossref","unstructured":"Johnson CD, Davidson BL (2010). Huntington\u2019s disease: progress toward effective disease-modifying treatments and a cure. Hum Mol Genet, 19:R98-R102.","DOI":"10.1093\/hmg\/ddq148"},{"key":"key-10.14336\/AD.2021.0404-50","doi-asserted-by":"crossref","unstructured":"Quintanilla RA, Johnson GV (2009). Role of mitochondrial dysfunction in the pathogenesis of Huntington\u2019s disease. Brain Res Bull, 80:242-247.","DOI":"10.1016\/j.brainresbull.2009.07.010"},{"key":"key-10.14336\/AD.2021.0404-51","doi-asserted-by":"crossref","unstructured":"Borgia D, Malena A, Spinazzi M, Desbats MA, Salviati L, Russell AP, et al. (2017). Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients. Hum Mol Genet, 26:1087-1103.","DOI":"10.1093\/hmg\/ddx019"},{"key":"key-10.14336\/AD.2021.0404-52","doi-asserted-by":"crossref","unstructured":"Harmuth T, Prell-Schicker C, Weber JJ, Gellerich F, Funke C, Driessen S, et al. (2018). Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3. Front Mol Neurosci, 11:368.","DOI":"10.3389\/fnmol.2018.00368"},{"key":"key-10.14336\/AD.2021.0404-53","doi-asserted-by":"crossref","unstructured":"Ward JM, Stoyas CA, Switonski PM, Ichou F, Fan W, Collins B, et al. (2019). Metabolic and Organelle Morphology Defects in Mice and Human Patients Define Spinocerebellar Ataxia Type 7 as a Mitochondrial Disease. Cell Rep, 26:1189-1202 e1186.","DOI":"10.1016\/j.celrep.2019.01.028"},{"key":"key-10.14336\/AD.2021.0404-54","doi-asserted-by":"crossref","unstructured":"Rangaraju S, Solis GM, Thompson RC, Gomez-Amaro RL, Kurian L, Encalada SE, et al. (2015). Suppression of transcriptional drift extends C. elegans lifespan by postponing the onset of mortality. Elife, 4.","DOI":"10.7554\/eLife.08833"},{"key":"key-10.14336\/AD.2021.0404-55","doi-asserted-by":"crossref","unstructured":"Ishihara N, Nomura M, Jofuku A, Kato H, Suzuki SO, Masuda K, et al. (2009). Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat Cell Biol, 11:958-966.","DOI":"10.1038\/ncb1907"},{"key":"key-10.14336\/AD.2021.0404-56","doi-asserted-by":"crossref","unstructured":"Wakabayashi J, Zhang Z, Wakabayashi N, Tamura Y, Fukaya M, Kensler TW, et al. (2009). The dynamin-related GTPase Drp1 is required for embryonic and brain development in mice. J Cell Biol, 186:805-816.","DOI":"10.1083\/jcb.200903065"},{"key":"key-10.14336\/AD.2021.0404-57","doi-asserted-by":"crossref","unstructured":"Fahrner JA, Liu R, Perry MS, Klein J, Chan DC (2016). A novel de novo dominant negative mutation in DNM1L impairs mitochondrial fission and presents as childhood epileptic encephalopathy. Am J Med Genet A, 170:2002-2011.","DOI":"10.1002\/ajmg.a.37721"},{"key":"key-10.14336\/AD.2021.0404-58","doi-asserted-by":"crossref","unstructured":"Broeks A, Janssen HW, Calafat J, Plasterk RH (1995). A P-glycoprotein protects Caenorhabditis elegans against natural toxins. Embo j, 14:1858-1866.","DOI":"10.1002\/j.1460-2075.1995.tb07178.x"},{"key":"key-10.14336\/AD.2021.0404-59","doi-asserted-by":"crossref","unstructured":"Kurz CL, Shapira M, Chen K, Baillie DL, Tan M-W (2007). Caenorhabditis elegans pgp-5 is involved in resistance to bacterial infection and heavy metal and its regulation requires TIR-1 and a p38 map kinase cascade. Biochemical and biophysical research communications, 363:438-443.","DOI":"10.1016\/j.bbrc.2007.08.190"},{"key":"key-10.14336\/AD.2021.0404-60","doi-asserted-by":"crossref","unstructured":"Tang B, Seredenina T, Coppola G, Kuhn A, Geschwind DH, Luthi-Carter R, et al. (2011). Gene expression profiling of R6\/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington\u2019s disease. Neurobiology of disease, 42:459-467.","DOI":"10.1016\/j.nbd.2011.02.008"},{"key":"key-10.14336\/AD.2021.0404-61","doi-asserted-by":"crossref","unstructured":"Ni Q, Su X, Chen J, Tian W (2015). Prediction of Metabolic Gene Biomarkers for Neurodegenerative Disease by an Integrated Network-Based Approach. BioMed Research International, 2015:432012.","DOI":"10.1155\/2015\/432012"},{"key":"key-10.14336\/AD.2021.0404-62","doi-asserted-by":"crossref","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. (1996). Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell, 87:493-506.","DOI":"10.1016\/S0092-8674(00)81369-0"},{"key":"key-10.14336\/AD.2021.0404-63","doi-asserted-by":"crossref","unstructured":"Van Raamsdonk JM, Metzler M, Slow E, Pearson J, Schwab C, Carroll J, et al. (2007). Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain. Neurobiol Dis, 26:189-200.","DOI":"10.1016\/j.nbd.2006.12.010"},{"key":"key-10.14336\/AD.2021.0404-64","doi-asserted-by":"crossref","unstructured":"Van Raamsdonk JM, Murphy Z, Slow EJ, Leavitt BR, Hayden MR (2005). Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Hum Mol Genet, 14:3823-3835.","DOI":"10.1093\/hmg\/ddi407"},{"key":"key-10.14336\/AD.2021.0404-65","doi-asserted-by":"crossref","unstructured":"Gray M, Shirasaki DI, Cepeda C, Andre VM, Wilburn B, Lu XH, et al. (2008). Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci, 28:6182-6195.","DOI":"10.1523\/JNEUROSCI.0857-08.2008"},{"key":"key-10.14336\/AD.2021.0404-66","doi-asserted-by":"crossref","unstructured":"Silva MC, Fox S, Beam M, Thakkar H, Amaral MD, Morimoto RI (2011). A genetic screening strategy identifies novel regulators of the proteostasis network. PLoS genetics, 7:e1002438-e1002438.","DOI":"10.1371\/journal.pgen.1002438"},{"key":"key-10.14336\/AD.2021.0404-67","doi-asserted-by":"crossref","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S (2004). Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature, 431:805-810.","DOI":"10.1038\/nature02998"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T18:51:38Z","timestamp":1633027898000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2021.0404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.14336\/ad.2021.0404","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}